Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Enveric Biosciences Inc
(NQ:
ENVB
)
0.8300
+0.0020 (+0.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Enveric Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
May 18, 2023
Via
Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 18, 2023
Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.
Via
Benzinga
Nasdaq Surges 100 Points; Walmart Raises Full-Year Outlook
May 18, 2023
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.09% to 33,451.95 while the NASDAQ rose 0.79% to 12,599.66. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 18, 2023
Via
Benzinga
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
May 18, 2023
Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office for a patent application involving EB-373, th
Via
Benzinga
Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share
May 15, 2023
Enveric Biosciences, Inc. (NASDAQ: ENVB) released its corporate update and reported financial results for the first quarter of 2023 ending March 31, 2023.
Via
Benzinga
EXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits
April 20, 2023
Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine.
Via
Benzinga
EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
April 14, 2023
Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental...
Via
Benzinga
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
April 03, 2023
The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.
Via
Benzinga
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
March 27, 2023
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses
Via
Benzinga
Enveric Creates Subsidiary Down Under To Further Next-Generation Psychedelics Program
March 21, 2023
Drug development biotech company Enveric Biosciences (NASDAQ: ENVB) has created Australia-based subsidiary Enveric Therapeutics Pty. Ltd. to support the progress of its next-generation psychedelics...
Via
Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered
Via
Benzinga
Enveric Biosciences: Novel Next-Gen Drug Discovery Platform Includes Rare Toad Enzyme
March 14, 2023
Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toad, plus the successful development of a...
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
March 13, 2023
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Via
Benzinga
Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
March 08, 2023
This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established...
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
March 06, 2023
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Via
Benzinga
The 7 Most Promising Psychedelic Stocks to Buy in February
February 05, 2023
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.
Via
InvestorPlace
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
What a year for psychedelics!
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 08, 2022
Via
Benzinga
15 Global Psychedelics Executives To Keep An Eye On In 2022
October 28, 2022
As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 29, 2022
Gainers
Via
Benzinga
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business...
Via
Benzinga
7 Psychedelics Stocks to Buy for a Big Drug Boom
August 30, 2022
These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
August 18, 2022
Via
Benzinga
7 Short-Squeeze Stocks to Put on Your Must-Watch List
August 16, 2022
If you want to zig while the bears zag, these short-squeeze stocks to put on your radar may make for handsome profits.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
August 08, 2022
Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
August 04, 2022
Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday!
Via
InvestorPlace
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
August 05, 2022
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share...
Via
Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
August 04, 2022
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.